[go: up one dir, main page]

WO2007010555A3 - Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof - Google Patents

Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof Download PDF

Info

Publication number
WO2007010555A3
WO2007010555A3 PCT/IN2006/000244 IN2006000244W WO2007010555A3 WO 2007010555 A3 WO2007010555 A3 WO 2007010555A3 IN 2006000244 W IN2006000244 W IN 2006000244W WO 2007010555 A3 WO2007010555 A3 WO 2007010555A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
crystalline forms
novel crystalline
moxifloxacin hydrochloride
moxifloxacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000244
Other languages
French (fr)
Other versions
WO2007010555A2 (en
Inventor
Reddy Manne Satyanarayana
Chakilam Nagaraju
Rajan Srinivasan Thirumalai
Ramprasad Achampeta Kodanda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSN Laboratories Pvt Ltd
Original Assignee
MSN Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MSN Laboratories Pvt Ltd filed Critical MSN Laboratories Pvt Ltd
Publication of WO2007010555A2 publication Critical patent/WO2007010555A2/en
Publication of WO2007010555A3 publication Critical patent/WO2007010555A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof.
PCT/IN2006/000244 2005-07-15 2006-07-13 Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof Ceased WO2007010555A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN948/CHE/2005 2005-07-15
IN948CH2005 2005-07-15

Publications (2)

Publication Number Publication Date
WO2007010555A2 WO2007010555A2 (en) 2007-01-25
WO2007010555A3 true WO2007010555A3 (en) 2007-04-12

Family

ID=37669239

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000244 Ceased WO2007010555A2 (en) 2005-07-15 2006-07-13 Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof

Country Status (1)

Country Link
WO (1) WO2007010555A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101933076A (en) * 2008-02-11 2010-12-29 高通Mems科技公司 Method of tuning an interferometric modulator display

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
ES2303768B1 (en) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. NEW CRYSTAL FORM OF MOXIFLOXACINO CHLORHYDRATE.
KR20150048920A (en) 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. Process for the synthesis of moxifloxacin hydrochloride
ES2316270B1 (en) * 2007-02-07 2010-02-09 Quimica Sintetica, S.A. NEW CRYSTAL FORM OF MOXIFLOXACINO CHLORHYDRATE ANHYDRA FORM IV.
ES2311391B1 (en) * 2007-02-07 2009-12-22 Quimica Sintetica, S.A. CRYSTAL FORM OF BASE MOXIFLOXACINO.
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
EP2342204A1 (en) * 2008-11-06 2011-07-13 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
CN101973992A (en) * 2010-10-09 2011-02-16 河南省健康伟业医药科技有限公司 Synthesizing method of moxifloxacin hydrochloride
CN102276603B (en) * 2011-07-14 2012-10-24 福建省福抗药业股份有限公司 Clean preparation method of moxifloxacin hydrochloride
CN102952131B (en) * 2011-08-29 2015-04-01 四川国为制药有限公司 Preparation method of moxifloxacin hydrochloride
CN102603738B (en) * 2012-02-24 2013-12-11 天津市汉康医药生物技术有限公司 Stable moxifloxacin hydrochloride compound
CN102924449B (en) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 Moxifloxacin hydrochloride H crystal form and preparation method thereof and pharmaceutical composition
CN112759590B (en) * 2020-11-19 2021-12-31 内蒙古源宏精细化工有限公司 Preparation method of moxifloxacin
CN115536658B (en) * 2022-09-09 2024-06-28 天方药业有限公司 Preparation method of moxifloxacin hydrochloride monohydrate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091619A1 (en) * 2003-04-09 2004-10-28 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091619A1 (en) * 2003-04-09 2004-10-28 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101933076A (en) * 2008-02-11 2010-12-29 高通Mems科技公司 Method of tuning an interferometric modulator display
CN101933076B (en) * 2008-02-11 2013-10-09 高通Mems科技公司 Interferometric modulator display and its tuning method

Also Published As

Publication number Publication date
WO2007010555A2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
WO2006127933A8 (en) Processes for preparing cinacalcet hydrochloride crystal form i
WO2008066935A3 (en) Crystalline forms of tigecycline and processes for preparation thereof
PL1743882T3 (en) Process for the preparation of isocyanates
WO2008021342A3 (en) Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone )
WO2007010555A3 (en) Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
IL188919A (en) Process for the preparation of mandipropamid and derivatives thereof and intermediates therefor
EP1934221A4 (en) An improved process for the preparation of beta-lactam antibiotic
WO2010056656A3 (en) Preparation of crystalline palonosetron hydrochloride
IL218351A0 (en) Process for the preparation of amines
TWI367257B (en) Process for the preparation of 2-butanol
IL181597A0 (en) Process for isolation of crystalline tacrolimus
WO2006034451A3 (en) Crystalline clopidogrel hydrobromide and processes for preparation thereof
WO2005102999A3 (en) Crystalline forms of fexofenadine hydrochloride and processes for their preparation
WO2007081907A3 (en) Crystalline forms of dolasetron base and processes for preparation thereof
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
IL175695A0 (en) Process for the preparation of valacyclovir hydrochloride
WO2009087669A3 (en) Palonosetron free base and process for its preparation
WO2006074230A3 (en) Method of making dorzolamide hydrochloride
WO2007063556A3 (en) An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
WO2008021518A3 (en) Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride
PL1928883T3 (en) Process for the preparation of irinotecan hydrochloride
WO2008056377A3 (en) Polymorphic forms of rimonabant
EP1797101A4 (en) An improved process for the preparation of levofloxacin hemihydrate
WO2007029096A3 (en) Novel polymorphic forms of clopidogrel hydrochloride

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06780528

Country of ref document: EP

Kind code of ref document: A2